Grants and Contributions

Sport science has traditionally centered on male athletes, either ignoring, or extrapolating findings to female athletes. Focusing on sex as a biological variable and gender as a social variable, this priority announcement (PA) aims to address research gaps in understanding the health of female athletes in the context of organized sport participation.
This PA is the result of a partnership between the CIHR Institute of Gender and Health (CIHR-IGH) and the Institute of Musculoskeletal Health and Arthritis (IMHA). For the purpose of this PA, sport is defined as "Activities that develop specific skills, and that are organized around competition and governed by rules" and will contribute to the National Women's Health Research Initiative (NWHRI) which is advancing a coordinated research program that addresses under-researched and high-priority areas of women's health and will ensure new evidence improves women's and gender-diverse people's care and health outcomes. The NWHRI promotes an intersectional lens to research and care to tackle persistent gaps for all women, including for Indigenous, Black, and women impacted by racism, women with disabilities, and members of Two-Spirit, lesbian, gay, bisexual, transgender, queer, intersex, and additional sexually and gender diverse (2SLGBTQI+) communities.
This PA is designed to support research that considers physical, biological, reproductive, psychological, emotional, cultural, and/or spiritual health as it relates to female athletes participating in sports across the life-course together with gender and other intersecting variables. Examples of research topics that would be considered for this initiative include:
• Sex-related factors that differently or disproportionately influence health outcomes of female athletes participating in sports.
• Impact of sports participation on puberty, menstruation, pregnancy, postpartum health, menopause, aging, and/or other sex-specific health outcomes among female athletes.
• Identification of unique health experiences of female athletes participating in sport with intersecting variables including ethnicity, (dis)ability, age, sexual orientation, and gender (including gender identity inclusive of trans, non-binary, gender non-conforming, and other gender diverse identities; gender relations; gender roles; and/or institutionalized gender dimensions);
• Identification of strategies to manage, support, and promote mental health and psychological safety of female athletes in the context of sport participation.

The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.

This PA will fund Cancer research in the following priority areas:

• Cancer Prevention and/or Early Detection of Cancer
o research that prevents the onset of cancer (lowers cancer risk) and/or reduces the severity of the disease through early detection when it is at its most treatable.
• Cancer Survivorship
o research that mitigates the challenges experienced along the cancer survivorship journey and improves the health outcomes for cancer survivors of all ages after cancer treatment ends.
o specifically in the areas of:
¿ Late and long-term effects of cancer treatment
¿ Survivors’ experiences and outcomes
¿ Models of care for cancer survivorship
o This PA will not fund research focused on improving end-of-life care.

This PA supports research that creates new knowledge and/or moves it into practice in the health system, communities, workplaces, and in the daily lives of Canadians.

The CIHR Institute of Circulatory and Respiratory Health (CIHR-ICRH) has the broad mandate of supporting research on the heart, lung, brain (stroke), blood, blood vessels, critical and intensive care, and sleep.
This Priority Announcement is focused on inherited blood disorders across the lifespan.
• The proposed research should inform the prevention and treatment of end-organ damage, the development of new and/or curative therapies and/or interventions aimed at improving quality of life.
• Research focusing on more than one (1) developmental or intergenerational period over the lifespan is encouraged. Examples include, but are not limited to:
o one developmental period before and after age 18, or
o different developmental periods across generations (e.g. biological parent and fetus or offspring), or
o two (2) developmental periods in females related to puberty, child-bearing age and menopause.
• Sex and gender consideration should be integrated as appropriate.

The CIHR Antimicrobial Resistance (AMR) Research Initiative supports the development of broader, more cohesive engagement and actions, methods and tools to combat AMR and improve antimicrobial use.

In alignment with CIHR’s commitment to equity, diversity and inclusion (EDI) in the research system, the Research Initiative champions EDI as a means to support excellence in research, training and knowledge mobilization. Therefore, we encourage people from diverse backgrounds, including groups underrepresented in science such as women and racial and ethnic minorities, to apply.

The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.
This PA will fund Breast Cancer research in the following priority areas:
• General Breast Cancer Research
o research that supports CIHR-ICR’s mandate in the area of Breast Cancer.
• Breast Cancer Prevention and/or Early Detection of Breast Cancer
o research that prevents the onset of breast cancer (lowers cancer risk) and/or reduces the severity of the disease through early detection when it is at its most treatable.
• Breast Cancer Survivorship
o research that mitigates the challenges experienced along the breast cancer survivorship journey and improves the health outcomes for breast cancer survivors of all ages after cancer treatment ends.
o specifically in the areas of:
¿ Late and long-term effects of cancer treatment
¿ Survivors’ experiences and outcomes
¿ Models of care for cancer survivorship
o This PA will not fund research focused on improving end-of-life care.
• This PA supports research that creates new knowledge and/or moves it into practice in the health system, communities, workplaces, and in the daily lives of Canadians.

Case studies, innovation and applied research

This project includes the launch of an “Ask a Pig Vet” service, the provision of in-person on online training workshops and webinars, and expands advertising and outreach efforts.

Enhance the conservation and recovery of species at risk by supporting Indigenous communities as they acquire, develop and apply the technical resources, skills and knowledge necessary to partner in Species at Risk Act (SARA) implementation

Enhance the conservation and recovery of species at risk by supporting Indigenous communities as they acquire, develop and apply the technical resources, skills and knowledge necessary to partner in Species at Risk Act (SARA) implementation

The purpose of the Oceans Management Contribution funding is to support the development and implementation of oceans conservation and management activities in Canada.